When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...

This is part of a continuing series describing antiviral antibodies to prevent and treat SARS-CoV-2 infections. In this series, we will discuss the fundamental nature of virus evolution, how ...

Participants with prior infection were more likely than vaccine recipients to retain some detectable antibodies.

Rapid Novor Inc., the world's leader in mass spectrometry (MS)-based antibody sequencing, published a peer-reviewed research article where REpAb ® antibody discovery platform was used to sequence a ...

In a recent study posted to the medRxiv* preprint server, researchers assessed longitudinal neutralizing antibody (nAb) responses before and after severe acute respiratory syndrome coronavirus 2 (SARS ...

Monoclonal antibodies have proven to be a potent tool in our ability to prevent and treat SARS-CoV-2 infections. The current epidemic is driven in part by naturally occurring variants that elude ...

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared ...

Both interferon-beta (IFN-beta) and glatiramer acetate have been established as effective disease-modifying agents for the treatment of patients with multiple sclerosis (MS). Both of these medications ...

Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range ...